Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Acacia Pharma
Acacia Pharma
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Barhemsys
Amisulpride
2020-02-26
2031-2038
—
Byfavo
Remimazolam
2020-10-06
2027-2033
Conscious sedation
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Amisulpride
major depressive disorder
,
healthy volunteers/patients
,
gastrointestinal microbiome
,
anorexia
,
anorexia nervosa
,
psychological stress
,
obsessive-compulsive disorder
,
compulsive behavior
,
compulsive personality disorder
,
chronic kidney failure
,
therapeutic equivalency
,
bipolar disorder
,
intellectual disability
,
postoperative nausea and vomiting
,
vomiting
,
nausea
,
dementia
,
psychophysiologic disorders
,
anxiety disorders
,
somatoform disorders
,
sialorrhea
,
schizophrenia
,
psychotic disorders
,
depression
,
mental disorders
,
treatment-resistant schizophrenia
,
depressive disorder
,
schizophrenia spectrum and other psychotic disorders
,
alzheimer disease
,
tardive dyskinesia
,
dyskinesias
,
prodromal symptoms
,
metabolic syndrome
,
hyperprolactinemia
,
syndrome
,
chronic pain
,
myofascial pain syndromes
,
fibromyalgia
,
addictive behavior
,
treatment-resistant depressive disorder
,
diabetes mellitus
,
insulin resistance
,
microvascular angina
,
periodontal diseases
Enoblituzumab
psoriasis
,
osteoarthritis
,
atrophy
,
atopic dermatitis
,
eczema
,
dermatitis
Calcium dobesilate
lymphoma
,
follicular lymphoma
Lornoxicam
multiple myeloma
,
plasma cell neoplasms
Bos taurus adrenal cortex corticosteroids
leukemia
,
lymphoma
Anthracycline
myeloid leukemia
,
neoplasms
,
inflammatory breast neoplasms
,
thymoma
,
thymus neoplasms
,
prostatic neoplasms
,
ovarian neoplasms
,
pancreatic neoplasms
,
b-cell chronic lymphocytic leukemia
,
reactive arthritis
,
drug-related side effects and adverse reactions
,
vomiting
,
nausea
,
breast neoplasms
,
sarcoma
,
lymphoma
,
leukemia
,
myeloid leukemia acute
,
hodgkin disease
,
neoplasm metastasis
,
myelodysplastic syndromes
,
congenital abnormalities
,
megakaryoblastic leukemia acute
,
monocytic leukemia acute
,
myelomonocytic leukemia acute
,
refractory anemia with excess of blasts
,
erythroblastic leukemia acute
APD209
wasting syndrome
,
cachexia
Trinessa
polycythemia vera
,
duchenne muscular dystrophy
Fluoroquinolone
healthy volunteers/patients
Isoxaflutole
chronic renal insufficiency
,
kidney diseases
,
magnetic resonance imaging
,
breast neoplasms
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use